Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oral proteasome inhibitor maintenance for multiple myeloma.

Literature DB >> 30545778

Oral proteasome inhibitor maintenance for multiple myeloma.

Niels W C J van de Donk¹, Kwee Yong².

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 30545778 DOI： 10.1016/S0140-6736(18)33128-3

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. The CD38^low natural killer cell line KHYG1 transiently expressing CD16^F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.

Authors: Subhashis Sarkar; Sachin K S Chauhan; John Daly; Alessandro Natoni; Heather Fairfield; Robert Henderson; Emma Nolan; Dawn Swan; Jinsong Hu; Michaela R Reagan; Michael O'Dwyer
Journal: Cancer Immunol Immunother Date: 2020-01-09 Impact factor: 6.968

1 in total

Oral proteasome inhibitor maintenance for multiple myeloma.

1. The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.

1. The CD38^low natural killer cell line KHYG1 transiently expressing CD16^F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.